Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies

Martin J. Scotta Department of Biopharm Discovery, Glaxo Smith Kline Research & Development, Hertfordshire, UKCorrespondence[email protected]

Amanda Jowetta Department of Biopharm Discovery, Glaxo Smith Kline Research & Development, Hertfordshire, UK

Martin Orecchiaa Department of Biopharm Discovery, Glaxo Smith Kline Research & Development, Hertfordshire, UK

Peter Ertla Department of Biopharm Discovery, Glaxo Smith Kline Research & Development, Hertfordshire, UK

Larissa Ouro-Gnaoa Department of Biopharm Discovery, Glaxo Smith Kline Research & Development, Hertfordshire, UK

Julia Ticehursta Department of Biopharm Discovery, Glaxo Smith Kline Research & Development, Hertfordshire, UK

David Gowera Department of Biopharm Discovery, Glaxo Smith Kline Research & Development, Hertfordshire, UK

John Yatesa Department of Biopharm Discovery, Glaxo Smith Kline Research & Development, Hertfordshire, UK

Katie Poultona Department of Biopharm Discovery, Glaxo Smith Kline Research & Development, Hertfordshire, UK

Carol Harrisb Department of Protein & Cellular Sciences, Glaxo Smith Kline Research & Development, Hertfordshire, UK

Michael J. Mullinb Department of Protein & Cellular Sciences, Glaxo Smith Kline Research & Development, Hertfordshire, UK

Kathrine J. Smithb Department of Protein & Cellular Sciences, Glaxo Smith Kline Research & Development, Hertfordshire, UK

Alan P. Lewisc Department of Data & Computational Sciences, Glaxo Smith Kline Research & Development, Hertfordshire, UK

Nick Bartonc Department of Data & Computational Sciences, Glaxo Smith Kline Research & Development, Hertfordshire, UK

Michael L. Washburnd Experimental Medicine Unit, Glaxo Smith Kline Research & Development, Collegeville, PA, USA

Ruud de Wildta Department of Biopharm Discovery, Glaxo Smith Kline Research & Development, Hertfordshire, UK

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.